Elopak (OB:ELO) Stock Looks Cheap as Margins Strengthen and Capex Looms

Elopak went into this earnings day with a stock that has drifted over the past month, down roughly 4%, and only slightly ahead over three months. The story around the company has been about solid packaging demand, improving margins and a P/E that sits below both its global packaging peers and a discounted cash flow based value. Today’s Q2 print keeps that profitability thread alive. Revenue reached €303.9m and net profit margin across the last year is reported at 5.6%, higher than last year’s 4.2%. The gap between that earnings profile and the NOK35 share price is what matters now.

Is Elopak at NOK35 a genuine mispricing or a value trap masked by higher margins and TTM earnings of €68.0m? Compare the current P/E, DCF gap and peer multiples in the valuation analysis for Elopak.

Q2 2026 Earnings Summary

• Revenue, Q2 2026 vs. Q2 2025: €303.9m vs. €289.7m (up about 4.9%)
• Net Income, Q2 2026 vs. Q2 2025: €15.7m vs. €9.3m (up about 69.5%)
• Basic EPS, Q2 2026 vs. Q2 2025: €0.06 vs. €0.03 (up about 73.6%)
• Net Profit Margin, TTM to Q2 2026 vs. prior year: 5.6% vs. 4.2% (margin higher year on year)

Prefer clean visuals instead of another wall of earnings tables and margin figures? View Elopak’s full financial picture, including valuation, in an easy-to-scan visual format in our company report for Elopak.

Elopak bull case: margins hold under real pressure

Bulls argue Elopak can turn packaging demand and sustainability trends into structurally higher margins as new capacity ramps. Q2 gives some backing to that view, but with caveats. Group adjusted EBITDA margin of 14.8% came despite higher LDPE, aluminum and freight costs and before surcharge pricing is fully reflected. That suggests the margin base is not only about easy input costs. The Americas business is doing the heavy lifting. Carton and closure volumes there grew strongly and the regional margin improved to 22.9% as U.S. lines scaled up. EMEA margins also ticked higher despite softer equipment sales. The board still felt comfortable paying an H1 dividend that represents about half of normalized net profit. For a bull, the key milestone is holding profitability while cost headwinds and mix shifts bite. Q2 shows progress, although not a clean win.

Elopak bear case: growth, capex and execution friction

The bear worry is that Elopak faces muted growth, heavy capex and execution risk that together cap value. Q2 does not fully dismiss that. Group revenue growth is modest and year to date remains low in reported terms, even with Americas cartons growing strongly. Management openly flags softer plant based demand in the Americas and persistent weakness in ambient juice. That supports the concern about shrinking or sluggish categories. Capital intensity is visible through continued U.S. plant investment and a planned third line while leverage sits near 2.2x. The Nippon Dynawave mill incident is another test, since it tightens board supply and could slow near term growth even if insurance eventually offsets costs. Leadership risk is partly addressed with the appointment of Håkon Volldal as CEO, although he only takes over by early 2027. Bears can say execution milestones are mixed rather than clearly achieved.

Compare how Elopak’s margin story lines up against what the street is pricing in. See the consensus price target analysis for Elopak to check whether analysts think NOK35 already reflects this earnings progress or still leaves room for a different outcome.

Stay Ahead With Simply Wall St

If Elopak’s margin story and current NOK35 share price have your attention, register for free with Simply Wall St and add it to your Watchlist to track price against fair value and watch how each earnings print shifts the picture. After you take a position, use the Portfolio Command Center to cut through noise and focus on the essential portfolio alerts that matter for your holdings. For longer term context, tap into the Community to see how other investors are interpreting the same data and key developments. This way you can identify potential catalysts and risks early, and maintain a clear edge on the market.

Seeking Alternatives Beyond Elopak?

Some of the sharpest breakouts start quietly while interest is still low and prices have not yet been caught by fast momentum traders. Check fresh ideas before the crowd and act now.

• Spot resilient growers before they start flying by scanning a curated pool of stocks with strong downside protection through the 285 resilient stocks with low risk scores.
• Target potential breakout stories still under the radar for now by reviewing the curated 612 high quality undiscovered gems while the data is fresh and the window for early entry is open.
• Track powerful income ideas where cash returns drive the story by reviewing a hand picked set of 445 dividend fortresses before yields drop and valuations catch up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com